Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer (Q40750430)

23 September 2017

title

Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer (English)

1 reference

23 September 2017

0 references

Eddy S Yang

1

1 reference

23 September 2017

Carol A Maiorino

2

1 reference

23 September 2017

Bernard A Roos

3

1 reference

23 September 2017

Selena R Knight

4

1 reference

23 September 2017

Kerry L Burnstein

5

1 reference

23 September 2017

publication date

1 January 2002

1 reference

Molecular and Cellular Endocrinology

23 September 2017

published in

1 reference

23 September 2017

volume

186

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

69-79

1 reference

Cell-cycle dysregulation and the molecular mechanisms of prostate cancer

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

New functional activities for the p21 family of CDK inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Human primary prostate tumor cell line, ALVA-31: a new model for studying the hormonal regulation of prostate tumor cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Activation of the human androgen receptor through a protein kinase A signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Vitamin D: a modulator of cell proliferation and differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Hepatocyte growth factor and vitamin D cooperatively inhibit androgen-unresponsive prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900671-2

7 January 2021

10.1016/S0303-7207(01)00671-2

Identifiers

DOI

1 reference

23 September 2017

1 reference